NSE › Healthcare

Natco Pharma Limited (NATCOPHARM)

NSE · Healthcare · Drug Manufacturers - Specialty & Generic

₹929.10+1.32%

Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue

₹739 cr

Revenue YoY

-39.6%

Net profit

₹268 cr

Profit YoY

-34.1%

EPS

₹14.96

EPS estimate

₹7.69

Net margin

36.2%

EPS came in at 14.96 against a street estimate of 7.69 — a beat of 94.5%.

Key statistics

Market cap

₹16,504 cr

P/E

11.6

Forward P/E

16.9

P/B

1.79

Book value

₹514.92

EPS (TTM)

₹79.24

Dividend yield

0.54%

52-week high

₹1,226.80

52-week low

₹786.24

50-day MA

₹964.89

200-day MA

₹943.80

Beta

0.20

Analyst view

with an average price target of ₹1,021.22.

Shareholding

Promoters

50.99%

Institutions

12.46%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Natco Pharma Limited — free to start.

Google Play App Store

Other Healthcare companies

Sun Pharmaceutical Industries Limited Divi's Laboratories Limited Torrent Pharmaceuticals Limited Apollo Hospitals Enterprise Limited Cipla Limited Zydus Lifesciences Limited Lupin Limited Max Healthcare Institute Limited Mankind Pharma Ltd Laurus Labs Limited Lenskart Solutions Ltd Dr. Reddy's Laboratories Limited

Data updated 2026-08-05.